United States Food and Drug Administration

Public Webinar: Patient-Focused Drug Development (PFDD) Draft Guidance 3

Patient Experience Data in Clinical Trials: Lessons Learned

Patient Experience Data in Clinical Trials: Who to Ask and How to Ask

Public Meeting on Patient-Focused Drug Development for Vitiligo

Public Meeting on Patient-Focused Drug Development for Systemic Sclerosis

Public Meeting on PFDD for Stimulant Use Disorder

Public Meeting on CDER Standard Core Sets Clinical Outcome Assessments...

Public Meeting for Patient-Focused Drug Development on Vitiligo

Public Meeting on Patient-Focused Drug Development for Stimulant Use Disorder

Public Meeting on CDER Standard Core Sets Clinical Outcome Assessments...

Patient-Focused Drug Development Guidance: Methods to Identify What is Important to Patients and Select, Develop or Modify Fit-for-Purpose Clinical Outcome Assessments

Public Meeting for Patient-Focused Drug Development on Chronic Pain